Medicis’ Vanos Gains Expanded Skin Condition Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
Medicis' Class I corticosteroid Vanos (fluocinonide) was approved by FDA March 2 as a treatment for all inflammatory and pruritic skin conditions in patients 12 and older who are responsive to corticosteroids, the company said